CG Oncology Leaves California For Texas
CG Oncology, the publicly traded biotech company behind bladder cancer treatments, has relocated its corporate headquarters from Irvine, California, to Dallas, Texas. The company, which recently had a market valuation of about $7 billion, moved its headquarters to Pegasus Park earlier this year. The move gives CG Oncology access to Dallas’ growing life sciences ecosystem, along with talent, investors, strategic partners, modern facilities, infrastructure, and…